Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Pharmaceutical Distribution Services

Active

Federal

Response Deadline10/16/2026, 07:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract for Pharmaceutical Distribution Services involves providing specialized logistics support for prime contractors serving the Department of Veterans Affairs and Department of Defense Pharmaceutical Prime Vendor Programs. The scope of work includes managing cold chain transport and storage, coordinating shipments to CMOPs and TMOPs, and maintaining inventory levels to ensure an uninterrupted supply of medical products delivered to program hubs. The contractor must operate in strict compliance with the Drug Supply Chain Security Act and Good Distribution Practices. This opportunity is categorized under NAICS code 424210 and is associated with Nac Pharmaceuticals. Interested parties should note the response deadline of October 16, 2026.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79727R0039.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedOct 2

subcontract

Response DeadlineOct 16

Submission deadline

Response Deadline

10/16/2026, 07:30:00 PM UTCin 14 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Performs pharmaceutical logistics for prime contractors delivering to VA and DoD Pharmaceutical Prime Vendor Programs. Manages cold chain transport and storage, coordinates shipments to CMOPs and TMOPs, and maintains inventory for an uninterrupted supply. Complies with the Drug Supply Chain Security Act (DSCSA) and Good Distribution Practices (GDP). Delivers product to Prime Vendor Program hubs.

Similar Contracts

Same NAICS industry code

Pharmaceutical Supplies (Preventative & Treatment)This subcontract opportunity is for the provision of pharmaceutical supplies to support reproductive health projects managed by the Virginia Department of Health. The selected vendor will be responsible for supplying medications used in the treatment of STIs, including antibiotics for syphilis, gonorrhea, and chlamydia, as well as HIV prevention tools such as PrEP, PEP, and Doxy-PEP medications and HPV vaccines. The scope of work includes the delivery of these medications and vaccines directly to various clinical sites throughout the state of Virginia. To be eligible for this contract, providers must hold a licensed pharmaceutical distributor certification. The solicitation is categorized under NAICS code 424210 and is open for responses until October 22, 2026. This role serves as a critical support function for prime contractors tasked with executing public health initiatives across the state.

Virginia Department of Health

POSTED

DEADLINE

ALBENDAZOLE TABLETS

Solicitation # SPE2DP-27-T-0027

Solicitation SPE2DP-27-T-0027 is a fixed-price procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for 168 bottles of Albendazole Tablets, USP. Each bottle contains two 200 mg tablets and must be stored at controlled room temperature between 20 and 25 degrees Celsius. The drug is regulated by the FDA and is classified as a Type I Code M item with a non-extendable shelf life of 24 months. Delivery is required FOB Destination to the 0189 CS BN CO A Composite AWCF SSA at Fort Bragg, North Carolina, with a required delivery date of September 29, 2026, and a delivery window of 20 days after order. The contract mandates strict adherence to pharmaceutical and military standards, requiring marking and labeling according to Medical Marking Standard No. 1 and general packaging per ASTM D3951, unless the material is deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies. Palletization must comply with RP001. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses regarding small business representations, cybersecurity for covered defense information, and the Buy American and Balance of Payments Program.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MICONAZOLE NITRATE POW

Solicitation # SPE2DP-27-T-0028

Solicitation SPE2DP-27-T-0028 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Miconazole Nitrate Antifungal Foot Powder. The government requires two cases of the product, identified by NSN 6505-01-667-9897, with a non-extendable shelf life of 24 months. The items must be stored at controlled room temperature in a cool, dry place and must be marked according to the latest edition of Medical Marking Standard No. 1. Delivery is required FOB Destination to the Vermont National Guard in Colchester, Vermont, with an original required delivery date of October 2, 2026, and a delivery window of 20 days after order. The contract mandates strict adherence to FDA regulations and DLA packaging and quality requirements. If the material is deemed hazardous under Federal Standard No. 313-E, suppliers must provide Safety Data Sheets and labels compliant with OSHA Hazard Communication Standards and package the items per TQ requirement IP025; otherwise, commercial packaging per ASTM D3951 is required. All packaging must be labeled in accordance with MIL-STD-129. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons. Quotations must be submitted via the DIBBS portal by October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0012

Solicitation SPE2DP-27-T-0012 is a fixed-price request for the procurement of 3% strength Hydrogen Peroxide Topical Solution, an FDA-regulated over-the-counter liquid for external use. The requirement is for cases containing 24 bottles, with each bottle containing 4 ounces of solution. The product must have a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage is required at controlled room temperature between 20-25 degrees Celsius. Delivery is specified as FOB Destination to the 0553 CS BN CO A Composite at Fort Hood, Texas, with a required delivery date of October 2, 2026, and a lead time of 20 days. The contract mandates strict adherence to the DLA Master List of Technical and Quality Requirements, specifically regarding packaging and marking. Material must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for the product itself, though general shipment packaging must still follow MIL-STD-129. Packaging must comply with ASTM D3951 for non-hazardous materials or TQ requirement IP025 if deemed hazardous per FED-STD-313. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment requests. The solicitation also incorporates various FAR and DFARS clauses covering cybersecurity, safeguarding covered defense information, and domestic material restrictions under the Buy American Act.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJECT

Solicitation # SPE2DP-27-T-0018

Solicitation SPE2DP-27-T-0018 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Sodium Chloride Injection, USP. The required product is a 0.9% 1000ML IV plastic bag that is latex-free, with a non-extendable shelf life of 30 months. The unit of issue is defined as one package containing 12 units. Delivery is required within five days after receipt of order, with shipping, inspection, and acceptance all designated as FOB Destination. The contractor must adhere to strict storage and packaging standards, maintaining a controlled room temperature between 20°C and 25°C and protecting the product from freezing and excessive heat. Packaging must be commercial and comply with MIL-STD-2073-1E and special instructions MPWM00001 or MPWND0001, ensuring each unit is in a sealed container to prevent damage. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic sourcing, and hazardous material identification.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Dialysis Supplies and Medication ProcurementThis subcontract for Dialysis Supplies and Medication Procurement involves the provision of essential medical consumables and medications for prime contractors operating within Escambia County Corrections facility projects. The scope of work includes the procurement and delivery of dialysis kits, filters, tubing, and necessary medications, alongside comprehensive inventory management and the provision of Safety Data Sheets for all chemical supplies. The contractor is required to ensure timely delivery of all medical materials while maintaining strict compliance with HIPAA and OSHA standards. This opportunity is categorized under NAICS code 424210 and is managed through the Florida Purchasing agency, with a response deadline set for November 3, 2026.

POSTED

DEADLINE

in about 1 month

Cleaning Supplies & Chemical Vendor

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Green Cleaning Supplies Vendor

0906 Aq Co Det B Contracti

POSTED

DEADLINE

Supply of Citalopram Hydrobromide Tablets (20 MG)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Iohexol Injection, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Zolmitriptan Tablets (NSN 6505-01-523-0353)This subcontract involves the supply of prescription-grade Zolmitriptan Tablets, 2.5 MG, for prime contractors supporting DLA Troop Support medical supply contracts. The scope of work requires the delivery of 3,000 packages, with each package containing six tablets under NSN 6505-01-523-0353. All products must adhere strictly to FDA regulations, and the provider must maintain valid FDA registration and the necessary licensure for pharmaceutical distribution. Managed by the Department of Defense Medical Supply Chain Pharm FSA, the contract is categorized under NAICS code 424210. The place of performance is designated as Fort Bragg, North Carolina. Interested parties must adhere to the timeline established by the posting date of September 29, 2026, with a response deadline set for October 5, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DANTROLENE SODIUM F

Solicitation # SPE2DP-26-T-5359

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

Pharmaceutical Labeling and Packaging ServicesThis subcontract for Pharmaceutical Labeling and Packaging Services supports prime contractors on Department of Veterans Affairs pharmaceutical projects. The scope of work involves the production and delivery of compliant packaging components, specifically focusing on labels featuring unique NDC numbers and bottle caps that adhere to the American Academy of Ophthalmology color-coding system. To ensure operational integrity, the provider utilizes medical-grade adhesives to securely affix VA labels over existing contractor labels. Managed under NAICS code 323111 for Nac Pharmaceuticals, the opportunity was posted on October 2, 2026, with a response deadline of October 16, 2026. The contract ensures that all specialized labeling and packaging materials meet the strict regulatory and safety requirements necessary for pharmaceutical distribution within the VA system.

Commercial Printing (except Screen and Books)

POSTED

about 16 hours ago

DEADLINE

Latanoprost Ophthalmic Solution ManufacturingThis subcontract involves the manufacturing of Latanoprost Ophthalmic Solution to support prime contractors on pharmaceutical procurement projects for the Department of Veterans Affairs. The scope of work encompasses the entire production process, including chemical synthesis, formulation, and sterile filling into ocular medication containers. All operations must be conducted within cleanrooms using pharmaceutical-grade API and in strict adherence to current Good Manufacturing Practices. To ensure safety and standardization, the manufacturer must follow the American Academy of Ophthalmology’s uniform color-coding system for all labels and caps. The final deliverable consists of finished, labeled, and packaged solutions assigned a unique NDC number. This project is categorized under NAICS code 325412 and is managed through Nac Pharmaceuticals.

Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation # 36E79727R0039

The Department of Veterans Affairs Enterprise Procurement Office is initiating an unrestricted procurement under solicitation 36E79727R0039 for Latanoprost Ophthalmic Solution. This acquisition aims to establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The procurement is issued in commercial item format per FAR Part 12 under NAICS code 325412 and is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Strict labeling requirements are in place, requiring offerors to provide a unique NDC number and the exact drug name as it appears on the label. The contractor's label must be the sole label on the product, cannot be affixed over another label, and must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. The solicitation is expected to be issued around October 21, 2026, with a tentative closing date of November 4, 2026, though some metadata indicates a response deadline of October 16, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

6505--Prednisolone 1% Ophthalmic Solution

Solicitation # 36E79726R0037

The Department of Veterans Affairs, through the OPAL Enterprise Procurement Office, is soliciting offers for the procurement of Prednisolone Acetate 1% Ophthalmic Suspension. This unrestricted procurement is designated as a HUBZONE Small Business set-aside and aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract consists of a one-year base period with four pre-priced one-year option periods. Supplies will be distributed via the VA and DoD Pharmaceutical Prime Vendor Programs, with requirements for three package sizes: 5ml, 10ml, and 15ml bottles. Award will be made to a single responsible offeror for all line items based on the Lowest Price Technically Acceptable (LPTA) approach. To be considered technically acceptable, offerors must provide FDA-approved pharmaceuticals with unique 11-digit NDC numbers and demonstrate that manufacturing facilities are FDA cGMP acceptable. Strict packaging and labeling standards are required, including GS1-128 or HIBC linear bar codes and 2D data matrix bar codes per the Drug Supply Chain Security Act. Proposals must be submitted by October 14, 2026, and must include a signed SF-1449, a 0.5% cost recovery fee in the pricing, and a letter of commitment from the manufacturer if the offeror is not the producer.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Labeling and Packaging SupplierThis subcontract with Nac Pharmaceuticals for the Department of Veterans Affairs involves the supply of medical-grade pharmaceutical packaging for approximately 462,000 units. The scope of work includes providing 5 ML and 10 ML bottles designed for compatibility with 5.25 by 2 inch labels, specifically ensuring a 0.5 inch space for barcodes and lot numbers. The supplier is responsible for providing adhesive label stock that supports secure VA over-labeling without the need for additional over-labeling. This procurement falls under NAICS code 326199 and was posted on September 25, 2026, with a response deadline of October 15, 2026.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Prednisolone Acetate 1% Ophthalmic Suspension ManufacturerNac Pharmaceuticals is seeking a subcontractor to manufacture and supply Prednisolone Acetate 1% Ophthalmic Suspension for Department of Veterans Affairs pharmaceutical supply contracts. The selected provider will be responsible for the formulation, production, filling, and sealing of both 5 ML and 10 ML bottles within sterile manufacturing facilities. To qualify, the manufacturer must maintain FDA registration, ensure full cGMP compliance, and possess a unique NDC number. The annual delivery requirements consist of 392,107 bottles of the 5 ML size and 70,070 bottles of the 10 ML size. This subcontract opportunity falls under NAICS code 325412, with a response deadline of October 15, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Distribution ServicesThis subcontract for Pharmaceutical Distribution Services involves the supply and distribution of Glipizide Tablets to prime contractors supporting various government entities, including the VA, DoD, BOP, IHS, and FHCC. The scope of work encompasses comprehensive warehousing, inventory management, and FOB Destination shipping specifically tailored for Consolidated Mail Order Pharmacies and State Veterans Homes. To ensure product integrity, the operations utilize climate-controlled warehousing and specialized pharmaceutical transport vehicles for delivery to designated government destinations. Managed by Nac Pharmaceuticals under the Department of Veterans Affairs, the contract falls under NAICS code 424210, with a response deadline set for October 8, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the packaging and labeling of Glipizide Tablets to support prime contractors delivering pharmaceutical supplies to the VA, DoD, BOP, IHS, and FHCC. The scope of work includes bottling, blister packing, and the application of labels that meet specific VA and DoD requirements using specialized pharmaceutical machinery. All operations must strictly adhere to FDA cGMP standards and the requirements outlined in Section 5 of the contract scope to ensure the tablets are ready for final shipment. This opportunity is issued by Nac Pharmaceuticals under the Department of Veterans Affairs, with a response deadline of October 8, 2026.

All Other Miscellaneous Manufacturing

POSTED

DEADLINE

Glipizide Tablet ManufacturingNac Pharmaceuticals is seeking a subcontractor for the manufacturing of Glipizide Tablets to support pharmaceutical supply contracts for the Department of Veterans Affairs, DoD, BOP, IHS, and FHCC. The scope of work encompasses the entire production process, including the chemical synthesis of the active pharmaceutical ingredient, tablet formulation, compression, and rigorous quality control testing. The selected provider must utilize pharmaceutical grade manufacturing equipment and maintain strict compliance with FDA cGMP standards. Key deliverables include the finished Glipizide Tablets and the provision of an 11-digit National Drug Code number. This subcontract opportunity falls under NAICS code 325412, with a response deadline of October 8, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Glipizide Tablets

Solicitation # 36E79726R0031_1

The Department of Veterans Affairs National Acquisition Center is soliciting proposals for an unrestricted procurement of Glipizide Tablets in 5mg and 10mg strengths to support the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract consists of a one-year base period with four pre-priced one-year option periods. Award will be granted to the responsible offeror providing the lowest evaluated price among those meeting non-cost acceptability standards. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, with delivery terms set as FOB Destination. Technical requirements are stringent, requiring a unique 11-digit NDC number and specific unit-of-use packaging. Bottles must be cylindrical, have a minimum 120cc volume, a minimum 5.75 inch circumference, and utilize safety caps that are either convertible or deshellable; glass bottles are prohibited. Labeling must be exactly 5.25 by 2 inches and include GS1-128 or HIBCC compliant bar codes with a two-dimensional data matrix. Offerors must certify FDA approval via NDA, ANDA, or BLA and provide a Letter of Commitment if they are not the manufacturer. Proposals must be submitted electronically to the designated points of contact by the final deadline of October 8, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime Vendors

General Warehousing and Storage

POSTED

DEADLINE

Supply of Metoprolol Tartrate Active Pharmaceutical Ingredient (API)

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS